SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-09-002654
Filing Date
2009-09-29
Accepted
2009-09-29 17:22:50
Documents
4
Period of Report
2009-09-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k092309_dor.htm 8-K 30080
2 SECURITIES PURCHASE AGREEMENT f8k092309ex10i_dor.htm EX-10.1 227534
3 FORM OF COMMON STOCK PURCHASE WARRANT f8k092309ex10ii_dor.htm EX-10.2 85574
4 REGISTRATION RIGHTS AGREEMENT f8k092309ex10iii_dor.htm EX-10.3 203752
  Complete submission text file 0001213900-09-002654.txt   548739
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 091093793
SIC: 2834 Pharmaceutical Preparations